Top Tech Companies (719)
Don't see your company?
Create a company profile
California Contract Manufacturer - 858-259-0969, Pharmaceutical manufacturing, clinical packaging, aseptic bottle tip cap filling, lyophilization services
At Ellab, our mission is to reduce the time-to-market and risk of product loss for biotech and pharma companies across the globe. We do so through our reliable validation products and field services, continuous monitoring solutions, GMP consulting, and calibration services. As a validation and monitoring tech and service partner, we help biopharmaceutical companies meet compliance requirements and deadlines today, and tomorrow – allowing us to build confidence in consumer safety together. One way we’ve successfully done this, was during the COVID-19 pandemic, where our solutions enabled our customers to validate that their freezers were safe to store Covid vaccines – ultimately ensuring that they were safe use.
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our mission is to deliver impactful medicines and solutions for a healthier every day. This site is intended for residents of the United States and its territories. You are reminded to protect yourself against recruiting fraud from individuals, organizations or other entities claiming to represent Organon. All official Organon recruitment emails will come from accounts formatted as [email protected] or [email protected], and Organon will never conduct interviews by chat or email, or make job offers through social media or online forums. All candidates for roles at Organon will first meet with a recruiter and interview team, via Teams or in person. Organon will never ask you to make financial transactions on its behalf or ask you to receive or ship packages or goods. For more information on adverse event reporting, visit http://bit.ly/AEReporting. To read our community guidelines, visit http://bit.ly/OrganonCommunityGuidelines. Follow us on Twitter at Organon (@OrganonLLC). Follow us on Instagram at Organon (@OrganonLLC).
Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.
Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Community Guidelines: https://bit.ly/39x9gqy
NanoBiotech Pharma, Inc is a healthcare company that focuses & deals with the reversal of cardiovascular issues occurring in midlife to aged people.
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as NASH, obesity and cancer. Terns’ pipeline includes four clinical stage development programs including a THR-β agonist, an allosteric BCR-ABL inhibitor, an FXR agonist, a VAP-1 inhibitor, and a preclinical small-molecule GLP-1 receptor agonist program. For more information, please visit: www.ternspharma.com.
Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base. Follow us on Twitter @Colorcon
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers, and is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer. In 2020, G1 out-licensed global development and commercialization rights to its differentiated oral CDK4/6 inhibitor, lerociclib. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. View our social community guidelines here: https://www.g1therapeutics.com/social-guidelines
A clinical stage biopharmaceutical company.
.jpeg)
.png)
Trusted Tablets is an online pharmacy that offers affordable, high-quality medications to customers worldwide. Specializing in generic medications for conditions such as erectile dysfunction, we provide a wide selection of trusted, effective treatments at lower prices than traditional pharmacies. Our platform ensures privacy and convenience with discreet packaging and secure online transactions, allowing you to order medications from the comfort of your home. Trusted Tablets also offers fast, reliable global shipping, delivering your medications directly to your doorstep. With thousands of satisfied customers, we’re dedicated to making healthcare more accessible and affordable for everyone.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline includes two investigational oral SYK inhibitors, entospletinib and lanraplenib, which are being developed to treat acute myeloid leukemia (AML). Together the compounds have the potential to target mutations present in more than two-thirds of patients with AML. We are also advancing an oral CDK9 inhibitor, KB-0742, to treat patients with solid tumors addicted to oncogenic transcription factor activity. KB-0742 is the first investigational medicine from our internal discovery platform to enter the clinic. Beyond these three investigational compounds, we are progressing additional discovery programs, including one focused on the MYC TRN and another focused on the AR TRN. For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.
Reverie Labs is a pharmaceutical company that uses its innovative computational chemistry and machine learning tools to accelerate its drug discovery programs. Reverie's primary goal is to develop kinase inhibitors that address the unmet needs of patients.
A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals
Plexium is a drug development startup that leverages techniques from various physical-science and computational disciplines.
Particle Sciences is a full-service CDMO focused on formulation and GMP/GLP production, analytic and bioanalytic services. We provide an integrated suite of drug development services aimed at minimizing the time and risks of drug development. We focus on semisolids, suspensions, particulates and drug/device products, with additional specialized capabilities in sterile products and highly potent compounds. As our name implies, we are expert in fine-particle and nanotechnology approaches and regularly deal with challenging API's. Particle Sciences provides contract drug development services and brings over two decades of expertise providing an efficient suite of preformulation, formulation, analytic and manufacturing services. A responsive and collaborative approach ensures that the objectives of all clients, large and small, are successfully met on time and on budget with the highest degree of quality. Through a full range of pharmaceutical formulation, analytic, and clinical manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution designed to minimize the time and risk between discovery and the clinic.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,700 people across 41 countries.
Advancing market-access marketing through experiential strategy, effective value demonstration, and market-access-focused resource development. The value of innovative medical treatments often begins with an evaluation of cost. As former payers ourselves, we know. So we identify and assess evidence of economic, clinical, and humanistic value, then analyze it to effectively demonstrate the total value of medical innovations—and maximize commercial success.
